TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - CVS HEALTH Stock

Certificat

DE000SF96FD7

Delayed Deutsche Boerse AG 02:13:11 2024-07-16 pm EDT
5.75 EUR -1.88% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - CVS HEALTH
Current month-1.68%
1 month+0.69%
Date Price Change
24-07-16 5.75 -1.88%
24-07-15 5.86 +0.86%
24-07-12 5.81 -2.19%
24-07-11 5.94 -1.49%
24-07-10 6.03 0.00%

Delayed Quote Deutsche Boerse AG

Last update July 16, 2024 at 02:13 pm EDT

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SF96FD
ISINDE000SF96FD7
Date issued 2021-12-13
Strike 122.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.76
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.4
Lowest since issue 1.51
Spread 0.01
Spread %0.17%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
58.67 USD
Average target price
69.1 USD
Spread / Average Target
+17.77%
Consensus